T he novel influenza-A (H1N1) was first reported in Mexico and the South USA in 2009. The virus then quickly spreads worldwide, demonstrating efficient human-to-human transmission [1]. The pandemic started in India in the month of August 2009 and the index cases were reported from Pune. Soon the epidemic spreads itself to other parts of the country. H1N1 influenza-A 2009 pandemic strain is now responsible for periodic seasonal outbreaks of influenza in India.The most infections with the novel influenza-A (H1N1) have resulted in self-limiting, uncomplicated disease. The seasonal influenza virus infection has been associated with various neurological complications, mostly accompanied with cases of encephalitis and encephalopathy. There are very few reports about the neurological complications of influenza-A H1N1 virus in literature and the prevalence of these complications has not been evaluated yet. Reports from India pertaining to the neurological manifestations of H1N1 are limited to two case reports and a recent case series [2][3][4]. The present analysis is our experience from a tertiary care referral institute in South India admitting influenza-A cases with special reference to the neurological manifestation from July through August 2019.
MATERIALS AND METHODSWe retrospectively identified children aged from 1 month to 12 years with evidence of seasonal influenza-A and associated neurological symptoms admitted in a tertiary care teaching hospital in South India during July-August 2019. A confirmed case of seasonal influenza-A was defined as an individual with an influenza-like illness (ILI) with laboratory-confirmed influenza-A virus detected by reverse transcription polymerase chain reaction (RT-PCR) in nasopharyngeal swab. ILI was defined as fever (temperature of 100°F [37.8°C] or greater) with cough or sore throat in the absence of a known cause other than influenza.Eligible patients are identified and their case records are analyzed to collect demographic profile, clinical symptoms, neurological and other systemic findings, investigations results, lumbar puncture results, neuroimaging report, treatment given, and outcome. RT-PCR in the nasopharyngeal swab specimen was done based on the standard protocol in the accredited laboratory, brain magnetic resonance imaging (MRI) and computed tomography scan were done wherever required and reported by a neuroradiologist who had knowledge about patient's clinical condition. Lumbar puncture was done in all patients and cerebrospinal fluid (CSF) study was done in the same laboratory.